Crop Life Science Financials

NSE: CLSL

₹83.00

₹-4.25 (-4.87%)

As on 07-Sep-2026IST

Market cap

₹142 Cr

Revenue (TTM)

₹201 Cr

P/E Ratio

21.4

P/B Ratio

1.8

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	200.59	198.61	131.23	--	--	--
Total Income	202.42	200.72	132.03	--	--	--
Total Expenditure	185.05	185.99	119.45	--	--	--
EBITDA	15.54	12.62	11.77	--	--	--
Depreciation	4.83	3.23	3.71	--	--	--
EBIT	10.71	9.39	8.07	--	--	--
Interest	4.75	3.39	3.27	--	--	--
Other Income	1.83	2.11	0.80	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	7.80	8.11	5.60	--	--	--
Provision for Tax	2.19	2.09	1.53	--	--	--
Profit after Tax	5.60	6.02	4.07	--	--	--
Minority Interest	0.29	0.01	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	5.89	6.02	4.07	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	77.45	71.73	40.55	--	--	--
Minority Interest	3.90	4.19	--	--	--	--
Non-Current Liabilities	7.56	11.06	6.30	--	--	--
Current Liabilities	95.07	94.99	56.26	--	--	--
Total Liabilities	183.98	181.96	103.10	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	39.61	39.88	16.03	--	--	--
Current Assets	144.38	142.08	87.07	--	--	--
Total Assets	183.98	181.96	103.10	--	--	--
Total Debt*	40.59	31.28	26.01	--	--	--
Net Current Assets	49.31	47.09	30.82	--	--	--
Contingent Liabilities	0.98	2.22	2.22	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-2.10	-8.33	2.27	--	--	--
Cash Flow from Investing Activities	-3.50	-3.42	-4.48	--	--	--
Cash from Financing Activities	4.16	13.43	0.52	--	--	--
Net Cash Inflow / Outflow	-1.44	1.67	-1.69	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	3.44	3.51	3.39	--	--	--
Cash EPS (₹)	6.08	5.39	6.48	--	--	--
Adjusted Book Value (₹)	45.19	41.85	33.80	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-1.22	-4.86	1.90	--	--	--
Free Cash Flow per Share (₹)	-6.01	-9.74	-4.17	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	11.35	13.56	13.33	--	--	--
ROE (%)	7.51	10.72	10.04	--	--	--
ROA (%)	3.06	4.22	3.95	--	--	--
EBIT Margin (%)	5.34	4.73	6.15	--	--	--
Net Margin (%)	2.77	3.00	3.08	--	--	--
Cash Profit Margin (%)	5.20	4.65	5.93	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	1.00	51.35	--	--	--	--
EBIT Growth (%)	14.05	16.43	--	--	--	--
Net Profit Growth (%)	-6.90	47.77	--	--	--	--
EPS Growth (%)	-2.19	3.58	--	--	--	--
Book Value Growth (%)	7.99	76.87	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	14.84	10.47	--	--	--	--
Price / Book Value	1.13	0.88	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	7.31	6.24	2.99	--	--	--
Close Price (₹)	51.00	36.80	--	--	--	--
High Price (₹)	69.20	55.95	--	--	--	--
Low Price (₹)	37.55	36.50	--	--	--	--
Market Cap (₹ Cr)	87.42	63.08	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.52	0.44	0.64	--	--	--
Short term debt to equity ratio	0.45	0.34	0.41	--	--	--
Current Ratio	1.52	1.50	1.55	--	--	--
Quick Ratio	1.00	1.08	1.08	--	--	--
Interest Coverage	2.64	3.39	2.71	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	34.54	38.90	24.81	--	--	--
Asset Turnover	1.10	1.39	1.27	--	--	--
Receivable days	133.34	100.91	90.55	--	--	--
Inventory Days	80.71	60.65	72.84	--	--	--
Payable days	121.49	90.76	79.13	--	--	--
Cash Conversion Cycle	92.56	70.80	84.26	--	--	--